Chicago Partners Investment Group’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
7,922
+60
+0.8% +$10.3K 0.03% 476
2026
Q1
$1.37M Sell
7,862
-19
-0.2% -$3.25K 0.03% 431
2025
Q4
$1.38M Buy
7,881
+8
+0.1% +$1.3K 0.03% 376
2025
Q3
$1.24M Hold
7,873
0.03% 373
2025
Q2
$1.07M Sell
7,873
-1,318
-14% -$162K 0.03% 382
2025
Q1
$1.1M Buy
9,191
+5,408
+143% +$733K 0.04% 343
2024
Q4
$510K Buy
3,783
+94
+3% +$13.2K 0.02% 507
2024
Q3
$524K Buy
3,689
+1,159
+46% +$168K 0.02% 476
2024
Q2
$374K Sell
2,530
-296
-10% -$39.5K 0.01% 540
2024
Q1
$362K Sell
2,826
-23
-0.8% -$3.14K 0.02% 525
2023
Q4
$384K Buy
2,849
+273
+11% +$33.3K 0.02% 486
2023
Q3
$299K Sell
2,576
-206
-7% -$26.2K 0.02% 510
2023
Q2
$354K Buy
2,782
+156
+6% +$20.3K 0.02% 496
2023
Q1
$349K Sell
2,626
-182
-6% -$23.8K 0.02% 473
2022
Q4
$383K Buy
+2,808
New +$363K 0.02% 435
2022
Q3
Sell
-3,660
Closed -$454K 605
2022
Q2
$454K Buy
3,660
+1,097
+43% +$130K 0.03% 351
2022
Q1
$291K Buy
+2,563
New +$334K 0.02% 420
2018
Q4
Sell
-560
Closed -$57K 598
2018
Q3
$57K Buy
+560
New +$65.9K 0.01% 497

Other funds holding IBB

Chicago Partners Investment Group's IBB Position: Q2 2026 in Review

Chicago Partners Investment Group increased its iShares Biotechnology ETF (IBB) stake by 0.76% in Q2 2026, buying an estimated $10.3K and bringing the position to 7,922 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #476.

Chicago Partners Investment Group first reported a position in IBB in Q3 2018 and has held it in 18 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Chicago Partners Investment Group held 7,922 shares of iShares Biotechnology ETF worth $1.5M as of Q2 2026.
  • Chicago Partners Investment Group bought 60 iShares Biotechnology ETF shares in Q2 2026, an estimated $10.3K.
  • iShares Biotechnology ETF made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #476 holding.
  • Chicago Partners Investment Group first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 18 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.